- The headline Consumer Price Index rose 0.3% in January and was up 1.4% year-on-year. Removing food and energy prices, the core index was flat on the month and slowed to 1.4% year-on-year from 1.6% in December.
- Small business optimism deteriorated for the third month in a row in January. Underneath the headline, the employment indicators remained broadly positive. Initial jobless claims also edged lower to 793k last week.
- Health metrics moved in the right direction this week. New COVID-19 cases continued to trend down, falling below 100k per day. Meanwhile, the vaccine rollout continued to pick up, averaging 1.6 million per day.
- North American equity markets had another solid week, with the S&P 500 and S&P TSX indexes closing the week higher. Oil prices also continued to rally. Buoyed by falling COVID-19 cases and vaccine optimism, WTI surpassed US$59/barrel.
- Falling cases and hospitalization rates have prompted provinces to begin easing restrictions. This week Ontario joined others in lifting restrictions on non-essential businesses and reopening schools.
- Reopening must go hand-in-hand with increased vaccination. Deliveries of the Pfizer-BioNTech vaccine are expected to ramp up significantly next week, with the company expected to deliver four million doses by the end of March.
U.S. – Moving In The Right Direction
The second week of February was fairly light on the data front, with the Consumer Price Index (CPI) and the National Federation of Independent Business’s (NFIB) small business optimism index the two main releases. The headline CPI rose 0.3% in January and was up 1.4% year-on-year in the month, unchanged from December. Removing, food and energy, core prices were flat on the month and lost steam on a year-on-year basis, falling to 1.4% from 1.6% in December (Chart 1).
Given the scope of fiscal and monetary policy supports to-date and the large fiscal package currently in the works, a lively debate is taking place in economic circles regarding the potential for inflation to accelerate beyond desirable levels. As we discuss in a recent report, a pickup in inflation is highly likely as economic restrictions are lifted. But, given where inflation stands today, there is some room for it to run before it reaches a concerning pace. Supporting the narrative of higher inflation is the fact that many small businesses plan to raise prices. According to NFIB data, the share of firms planning to do so rose by 6 points to 28% in January – among the highest levels in the post-Great Recession period.
Speaking of small businesses, the headline NFIB confidence measure ticked down modestly for the third consecutive month in January. Pullbacks in the expectations subcomponents were the biggest drags on the headline measure. But, in what can be viewed as a sign of underlying resilience, the employment metrics remained broadly positive. Hiring plans held steady in January, while job openings and the share of firms raising and planning to raise worker compensation ticked up.
Signals from other labor market indicators were more mixed. Continuing jobless claims from regular state programs edged lower at the end of January, but, with an increase in pandemic-related programs, the total number swelled to just over 20 million. On a more positive note, data on initial jobless claims showed the latter falling by 19k to 793k last week – the lowest level in five weeks.
While the U.S. labor market struggles to dig itself out of the winter slowdown, there appears to be a light at the end of the tunnel. New COVID-19 cases continued to trend down this week, falling below 100k per day recently for the first time this year. At the same time, the pace of vaccinations is accelerating, with daily jabs averaging 1.6 million in recent days (Chart 2). The vaccine rollout should continue to gather speed (see report released today), hastening the end of the pandemic.
With health metrics continuing to move in the right direction, a loosening of restrictions and stronger consumer confidence should follow. Coupled with another likely jolt of fiscal stimulus, this bodes for the U.S. economy to expand at a solid clip this year. If the full $1.9 trillion American Rescue Plan package is passed, real GDP growth could run as high as 6% through 2021, enough to bring the level of GDP back to its pre-crisis trend by the end of the year. New COVID-19 variants are the main downside risk to this positive outlook. For now, their spread remains low, but it is increasing in several key states. This is something that we’ll be keeping a close eye on.
Canada – Economic Re-Opening 2.0
North American equity markets had another solid week, with both the S&P 500 and S&P TSX closing the week higher. Coming on the heels of last week’s gain, crude oil prices also continued to rally, stoked by vaccine optimism and expectations that faster growth in the second half of this year would accelerate the drawdown of inventories. The benchmark WTI price surpassed US$59 a barrel – a level last seen just prior to the onset of the global pandemic more than a year ago (Chart 1).
Recovery in oil prices is certainly good news for Canada’s energy sector. However, Canada’s economic fortunes continue to hinge on virus containment and the vaccination campaign. There was some reassuring news on both of these fronts this week. First and foremost, the number of COVID-19 cases have declined significantly since the start of the year. As a result, an increasing number of provinces have announced gradual re-opening plans. This week, Ontario joined other provinces in lifting restrictions, with non-essential businesses allowed to reopen with reduced capacity. Toronto and other hotspots will need to wait for another two weeks before schools and businesses will be allowed to re-open.
The recent easing of the restrictions will be welcomed by businesses, but widespread vaccinations is the only cure to this stop-and-go economy, particularly amid the spread of more contagious variants of the virus. On this front, Pfizer-BioNTech vaccine deliveries are expected to ramp up significantly starting next week. With retooling of the Pfizer plant which slowed earlier deliveries, now complete, it appears that the company will be able to deliver the contracted four million doses by the end of March. If vaccine rollout continues to pick up in the coming months as communicated by the government, we estimate it will still take until the end of 2021 for Canada to achieve herd immunity (Chart 2).
Concerns about hospital capacity have been a key trigger for Canadian provinces to tighten restrictions. International experiences indicate that hospitalizations can be more quickly reduced by focusing vaccinations on the elderly and other at-risk populations. As we discuss in a report published this week, the e